Logo image of YMAB

Y-MABS THERAPEUTICS INC (YMAB) Stock Analyst Ratings

NASDAQ:YMAB - Nasdaq - US9842411095 - Common Stock - Currency: USD

5.72  -0.32 (-5.3%)

After market: 5.72 0 (0%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to YMAB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.15. This target is 252.19% above the current price.
YMAB was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about YMAB.
In the previous month the buy percentage consensus was at a similar level.
YMAB was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
YMAB Historical Analyst RatingsYMAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -75 -68 -61 -54 -47 -40 -33 -26 -19 -12 -5 5 10 15

Price Target & Forecast

Price Low Median Mean High 5.7211.1121.9320.1527.30 - 94.23% 283.39% 252.19% 377.27%
YMAB Current Analyst RatingYMAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-05 Brookline Capital Initiate Buy
2024-11-18 Oppenheimer Initiate Outperform
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-10 Wedbush Reiterate Outperform -> Outperform
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-16 Cantor Fitzgerald Initiate Overweight
2024-08-13 BMO Capital Maintains Outperform -> Outperform
2024-08-13 Canaccord Genuity Maintains Buy -> Buy
2024-08-13 Morgan Stanley Maintains Underweight -> Underweight
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-11 Jones Trading Initiate Buy
2024-06-28 Truist Securities Initiate Buy
2024-05-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-06 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-04 BMO Capital Maintains Outperform -> Outperform
2024-03-04 Canaccord Genuity Maintains Buy -> Buy
2024-02-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-22 JP Morgan Maintains Underweight -> Underweight
2023-08-14 Morgan Stanley Maintains Underweight -> Underweight
2023-08-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-25 Canaccord Genuity Maintains Buy -> Buy
2023-06-07 Canaccord Genuity Reiterate Buy -> Buy
2023-05-15 B of A Securities Maintains Neutral -> Neutral
2023-05-10 Wedbush Upgrade Neutral -> Outperform
2023-05-10 Morgan Stanley Maintains Underweight
2023-05-09 Canaccord Genuity Maintains Buy
2023-04-04 HC Wainwright & Co. Maintains Buy